| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evolus, Inc. (EOLS) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 6 sells. EOLS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 604.7K | $4.48M | - | |
| Other | 427.4K | $3.17M | - | |
| Dir | 321.1K | $2.38M | - | |
| CFO | 226.1K | $1.68M | - | |
| Dir | 134.2K | $994.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | Avelar Rui68 | See Remarks | Sell | 2,211 | $10.27 | $22,706.97 | -0.6% | -17.2% | +33.3% | |
| Aug 16, 2023 | Beaver Sandra67 | Chief Financial Officer | Sell | 2,211 | $10.27 | $22,706.97 | -1.9% | -17.2% | +33.3% | |
| Aug 16, 2023 | Moatazedi David67 | See Remarks | Sell | 14,778 | $10.27 | $151,770.06 | -2.1% | -17.2% | +33.3% | |
| Aug 15, 2023 | Malik Vikram54 | Director | Buy | 174,967 | $7.41 | $1,296,505.47 | +174.0% | -20.4% | +34.7% | |
| Mar 27, 2023 | Moatazedi David67 | See Remarks | Sell | 6,110 | $8.47 | $51,751.70 | -1.0% | -12.2% | +64.7% | |
| Mar 14, 2023 | Moatazedi David67 | See Remarks | Sell | 64,211 | $8.47 | $543,796.54 | -9.4% | -5.5% | +61.2% | |
| Mar 14, 2023 | Avelar Rui68 | See Remarks | Sell | 14,906 | $8.47 | $126,237.42 | -4.2% | -5.5% | +61.2% |